Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 172

The DOI matches its Crossref record.

Markers of survival and metastatic potential in childhood CNS primitive neuro-ectodermal brain tumours: an integrative genomic analysis

Open access
Picard, Daniel, Miller, Suzanne, Hawkins, Cynthia E, Bouffet, Eric, Rogers, Hazel A, Chan, Tiffany SY, Kim, Seung-Ki, Ra, Young-Shin, Fangusaro, Jason, Korshunov, Andrey, Toledano, Helen, Nakamura, Hideo, Hayden, James T, Chan, Jennifer, Lafay-Cousin, Lucie, Hu, Pingzhao, Fan, Xing, Muraszko, Karin M, Pomeroy, Scott L, Lau, Ching C, Ng, Ho-Keung, Jones, Chris, Van Meter, Timothy, Clifford, Steven C, Eberhart, Charles, Gajjar, Amar, Pfister, Stefan M, Grundy, Richard G, Huang, Annie·2012·The Lancet Oncology

Abstract

Background Childhood Central Nervous System Primitive Neuro-Ectodermal brain Tumours (CNS-PNETs) are highly aggressive brain tumours for which molecular features and best therapeutic strategy remains unknown. We interrogated a large cohort of these rare tumours in order to identify molecular markers that will enhance clinical management of CNS-PNET. Methods Transcriptional and copy number profiles from primary hemispheric CNS-PNETs were examined using clustering, gene and pathways enrichment analyses to discover tumour sub-groups and group-specific molecular markers. Immuno-histochemical and/or gene expression analyses were used to validate and examine the clinical significance of novel sub-group markers in 123 primary CNS-PNETs. Findings Three molecular sub-groups of CNS-PNETs distinguished by primitive neural (Group 1), oligo-neural (Group 2) and mesenchymal lineage (Group 3) gene expression signature were identified. Tumour sub-groups exhibited differential expression of cell lineage markers, LIN28 and OLIG2, and correlated with distinct demographics, survival and metastatic incidence. Group 1 tumours affected primarily younger females; male: female ratios were respectively 0.61 (median age 2.9 years; 95% CI: 2.4–5.2; p≤ 0.005), 1.25 (median age 7.9 years; 95% CI: 6–9.7) and 1.63 (median age 5.9 years; 95% CI: 4.9–7.8) for group 1, 2 and 3 patients. Overall outcome was poorest in group 1 patients which had a median survival of 0.8 years (95% CI: 0.47–1.2; p=0.019) as compared to 1.8 years (95% CI: 1.4–2.3) and 4.3 years; (95% CI: 0.82–7.8) respectively for group 2 and 3 patients. Group 3 tumours had the highest incidence of metastases at diagnosis; M0: M+ ratio were respectively 0.9 and 3.9 for group 3, versus group 1 and 2 tumours combined (p=0.037). Interpretation LIN28 and OLIG2 represent highly promising, novel diagnostic and prognostic molecular markers for CNS PNET that warrants further evaluation in prospective clinical trials.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s1470-2045(12)70257-7

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 172

Metadata

Authors
Picard, D., Miller, S., Hawkins, C. E., Bouffet, E., Rogers, H. A., Chan, T. S., Kim, S.-K., Ra, Y.-S., Fangusaro, J., Korshunov, A., Toledano, H., Nakamura, H., Hayden, J. T., Chan, J., Lafay-Cousin, L., Hu, P., Fan, X., Muraszko, K. M., Pomeroy, S. L., Lau, C. C., Ng, H.-K., Jones, C., Van Meter, T., Clifford, S. C., Eberhart, C., Gajjar, A., Pfister, S. M., Grundy, R. G., & Huang, A.
Venue
The Lancet Oncology
Publisher
Elsevier BV
Published
2012-08
Volume
13
Issue
8
Pages
838-848
ISSN
1470-2045 (ISSN-L)
OpenAlex
W2166326729
Cited by
172
References
0
FWCI
8.74
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Markers of survival and metastatic potential in childhood CNS primitive neuro-ectodermal brain tumours: an integrative genomic analysis. https://app.cochat.ai/papers/10.1016/s1470-2045(12)70257-7
The paper
Picard, D., Miller, S., Hawkins, C. E., Bouffet, E., Rogers, H. A., Chan, T. S., Kim, S.-K., Ra, Y.-S., Fangusaro, J., Korshunov, A., Toledano, H., Nakamura, H., Hayden, J. T., Chan, J., Lafay-Cousin, L., Hu, P., Fan, X., Muraszko, K. M., Pomeroy, S. L., . . . Huang, A. (2012). Markers of survival and metastatic potential in childhood CNS primitive neuro-ectodermal brain tumours: an integrative genomic analysis. The Lancet Oncology. https://doi.org/10.1016/s1470-2045(12)70257-7

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.